Trailing-twelve-month (TTM) revenue is $12.48 Billion with a year-over-year growth of +8.74%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $3,120,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-22 |
| Q4 FY2025Period ended 2025-12-31 | $3,087,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-31 | $2,937,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-28 |
| Q2 FY2026Period ended 2026-06-30 | $3,341,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-28 |
| TTM revenue | $12,485,000,000 |
Current P/S: $69,092,704,350 market capitalization ÷ $12,485,000,000 TTM revenue = 5.53x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $3.34B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Hotel, Other | $73M | $79M | $102M | $178M | $232M | $252M |
| Hotel, Owned | $421M | $598M | $1.1B | $1.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | N/A | N/A | N/A | N/A | N/A | $2.5B |
| Total of All Other Countries | $714M | $1.0B |
$12.48B
$12.48 Billion
+8.74%
vs. $11.48B a year ago (TTM)
+25.41%
5 Year compound annual growth rate
1 Year
+8.74%
3 Year
+8.53%
5 Year
+25.41%
10 Year
+5.58%
15 Year
+2.70%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $12.04B | +$865.00M | +7.74% |
| 2024 | $11.17B | +$939.00M | +9.17% |
| 2023 | $10.23B | +$1.46B | +16.66% |
| 2022 | $8.77B | +$2.98B | +51.57% |
| 2021 | $5.79B | +$1.48B | +34.39% |
| 2020 |
TTM Growth
+8.74%
3-Year CAGR
+8.53%
5-Year CAGR
+25.41%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.3B |
| N/A |
| Management and Franchise | $945M | $1.5B | $2.1B | $2.4B | $2.6B | $2.8B |
|---|
| Management Service, Base | $123M | $176M | $294M | $342M | $369M | $376M |
|---|
| Management Service, Incentive | $38M | $98M | $196M | $274M | $290M | $313M |
|---|
| Reimbursement Revenue | $2.7B | $3.3B | $5.0B | $5.8B | $6.4B | $7.1B |
|---|
| $2.2B |
| $2.4B |
| N/A |
| UNITED STATES | $3.6B | $4.8B | $6.9B | $8.0B | $8.8B | $9.5B |
|---|
| $4.31B |
| ($5.14B) |
| (54.43%) |
| 2019 | $9.45B | +$546.00M | +6.13% |
| 2018 | $8.91B | +$5.50B | +161.63% |
| 2017 | $3.40B | ($3.17B) | (48.24%) |
| 2016 | $6.58B | +$3.45B | +110.63% |
